HLA associations with infliximab-induced liver injury. (Record no. 30601976)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01838 a2200577 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518083705.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 202107s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1473-1150 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1038/s41397-020-0159-0 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Bruno, Christopher D |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20210707 |
245 00 - TITLE STATEMENT | |
Title | HLA associations with infliximab-induced liver injury. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The pharmacogenomics journal |
Date of publication, distribution, etc. | 10 2020 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 681-686 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Inflammatory Agents |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Chemical and Drug Induced Liver Injury |
General subdivision | diagnosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Child |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genome-Wide Association Study |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HLA Antigens |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HLA-B39 Antigen |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HLA-B8 Antigen |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HLA-DQ beta-Chains |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HLA-DRB1 Chains |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infliximab |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pharmacogenetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pharmacogenomic Variants |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phenotype |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Polymorphism, Single Nucleotide |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Retrospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Assessment |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Young Adult |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fremd, Brandon |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Church, Rachel J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Daly, Ann K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Aithal, Guruprasad P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Björnsson, Einar S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Larrey, Dominique |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Watkins, Paul B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chow, Christina R |
773 0# - HOST ITEM ENTRY | |
Title | The pharmacogenomics journal |
Related parts | vol. 20 |
-- | no. 5 |
-- | p. 681-686 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1038/s41397-020-0159-0">https://doi.org/10.1038/s41397-020-0159-0</a> |
Public note | Available from publisher's website |
No items available.